MedPath

The efficacy of omega – 3 in treatment of Acne – Vulgaris: a DOUBLE BLIND STUDY

Not Applicable
Conditions
Acne Vulgaris.
Acne vulgaris
Registration Number
IRCT2012080110471N1
Lead Sponsor
Kurdestan University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

inclusion criteria: acne- vulgaris patients have indication of systemic therapy treatment
exclusion criteria:diabetes mellitus; hypertension ; significant pulmonary, hepatic or renal disease ; typical angina or myocardial infarction; use of antihypertensive, oral hypoglycemic or lipid lowering agent or anticoagulant drug; glucocorticoids equivalent to greater than 10 mg Prednisolone daily; all pregnant or lactating women.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvment skin lesion such as comedone,papules,pustules,nodules. Timepoint: 1 month. Method of measurement: with count the facial lesion.
Secondary Outcome Measures
NameTimeMethod
Improvement skin lesion such as comedone, papules, pustules, nodules. Timepoint: 1 month. Method of measurement: with count the facial lesion.
© Copyright 2025. All Rights Reserved by MedPath